Home > Insider Trading > Filing (0001209191-18-010129)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557290	A Stuart Arbuckle	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp\Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-02-12	875	$150.78	61,650	No	4	S	Direct
Common Stock	Disposition	2018-02-12	800	$152.27	60,850	No	4	S	Direct
Common Stock	Disposition	2018-02-12	3,879	$153.07	56,971	No	4	S	Direct
Common Stock	Disposition	2018-02-12	1,270	$153.80	55,701	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	140	Indirect	401(k)

Footnotes

Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $150.78 (range $150.42 to $151.20).
Open market sales reported on this line occurred at a weighted average price of $152.27 (range $151.67 to $152.62).
Open market sales reported on this line occurred at a weighted average price of $153.07 (range $152.67 to $153.66).
Open market sales reported on this line occurred at a weighted average price of $153.80 (range $153.67 to $153.99).